Sternchemie Expands Its Product Portfolio
According to Sternchemie, non-GMO soy lecithin quality and availability have been greatly reduced in recent times, which is why the company decided to respond to these market changes with new partnerships and an expanded product portfolio. As far as the latter is concerned, that means the introduction of new quality standards in many areas and focusing more on rapeseed.
“With the introduction of a ‘Select’ grade we’re documenting the fact that we use specially selected raw materials for these products and apply special quality parameters, including strict controls of contaminants,” says Dr. Rabeler, business development manager, Sternchemie. “Our state-of-the-art technology and rigorous requirements for our production partners give us the ability to meet the highest demands.”
As sunflower lecithin alone cannot fill the gap in non-GMO lecithin, Sternchemie is focusing more on rapeseed, whose functionality is very similar to soy lecithin in many applications. The existing rapeseed portfolio is accordingly being expanded with new solutions that offer full-function alternatives to soy lecithin, especially in situations where flavor and oxidation problems can arise, such as in chocolate or instant products.
Sternchemie is also broadening its SternPhil range of hydrolyzed products, especially in view of the growing market for plant-based products. Dr. Rabeler stated: “Hydrolyzed lecithin is easy to incorporate into products, has outstanding emulsifying properties, and interacts effectively with proteins. This can be a great advantage, especially in plant-based products like non-dairy alternatives.”